$75.52-$0.89 (-1.16%)
Calvert US Mid-Cap Core Responsible Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
Loading market information…
NASDAQ · CANC · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tema Oncology ETF’s forward annual dividend is $0.02 per share, paid annual. The forward yield is 0.05% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$75.52-$0.89 (-1.16%)
Calvert US Mid-Cap Core Responsible Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
$42.74-$0.89 (-2.04%)
Matthews Asia Innovators Active ETF’s quoted price sits in the lower half of its reported 52-week range, 29.97% below the high.
$126.40-$2.15 (-1.67%)
Invesco S&P Spin-Off ETF’s quoted price sits in the upper half of its reported 52-week range, 15.98% below the high.
$12.65-$0.44 (-3.36%)
Amplify Lithium & Battery Technology ETF’s quoted price sits in the lower half of its reported 52-week range, 30.03% below the high.
$35.19-$0.26 (-0.74%)
Pacer Swan SOS Moderate (January) ETF’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$136.25-$2.42 (-1.74%)
Matrix Advisors Value ETF’s quoted price sits in the upper half of its reported 52-week range, 4.61% below the high.
$41.76-$0.54 (-1.29%)
Overlay Shares Hedged Large Cap Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
$56.57-$0.81 (-1.4%)
ProShares - Online Retail ETF’s quoted price sits in the lower half of its reported 52-week range, 11.53% below the high.
